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Abstract 
Background: Early‑life stress can leave persistent epigenetic marks that may modulate vulnerability to psychiatric 
conditions later in life, including anxiety, depression and stress‑related disorders. These are complex disorders with 
both environmental and genetic influences contributing to their etiology. Methyl‑CpG Binding Protein 2 (MeCP2) has 
been attributed a key role in the control of neuronal activity‑dependent gene expression and is a master regulator of 
experience‑dependent epigenetic programming. Moreover, mutations in the MECP2 gene are the primary cause of 
Rett syndrome and, to a lesser extent, of a range of other major neurodevelopmental disorders. Here, we aim to study 
the interaction of MeCP2 with early‑life stress in variables known to be affected by this environmental manipulation, 
namely anxiety‑like behavior and activity of the underlying neural circuits.
Methods: Using Mecp2 heterozygous and wild‑type female mice we investigated the effects of the interaction of 
Mecp2 haplodeficiency with maternal separation later in life, by assessing anxiety‑related behaviors and measuring 
concomitant c‑FOS expression in stress‑ and anxiety‑related brain regions of adolescent females. Moreover, arginine 
vasopressin and corticotropin‑releasing hormone neurons of the paraventricular hypothalamic nucleus were analyzed 
for neuronal activation.
Results: In wild‑type mice, maternal separation caused a reduction in anxiety‑like behavior and in the activation 
of the hypothalamic paraventricular nucleus, specifically in corticotropin‑releasing hormone‑positive cells, after the 
elevated plus maze. This effect of maternal separation was not observed in Mecp2 heterozygous females that per se 
show decreased anxiety‑like behavior and concomitant decreased paraventricular nuclei activation.
Conclusions: Our data supports that MeCP2 is an essential component of HPA axis reprogramming and underlies 
the differential response to anxiogenic situations later in life.
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Introduction
Early-life stress (ELS) constitutes a major risk factor 
for the development of psychiatric disorders, including 
anxiety disorders. These disorders are the most frequent 
mental disorders and impose an enormous societal and 
economic burden [1, 2]. Here, we address the potential 
involvement of decreased functionality of the X-linked 
methyl-CpG binding protein 2 (MeCP2), in mediat-
ing ELS effects on susceptibility to the development of 
abnormal anxious responses.
MeCP2 is a multifaceted protein with roles in tran-
scriptional regulation, epigenetic programs, alternative 
splicing, microRNA processing and chromatin remod-
eling, thereby facilitating several biological processes [3]. 
In particular, MeCP2 has been attributed a key role in the 
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control of neuronal activity-dependent gene expression 
[4, 5] and in experience-dependent epigenetic program-
ming [6, 7]. As an epigenetic reader, MeCP2 controls crit-
ical periods of postnatal development, which are periods 
of high plasticity and sensitivity to the environment [8].
The activity of the hypothalamic-pituitary-adrenal 
(HPA) axis is characterized by a prominent critical 
period of plasticity [9]. Adverse events occurring during 
this period are engraved in ‘permanent’ epigenetic marks, 
with MeCP2 being a master regulator of these processes 
[6]. This way, early life adversity will have an impact in 
the stress response later in life, when individuals are 
faced with a stressor [9]. Moreover, MeCP2 is known to 
regulate the expression of corticotropin-releasing hor-
mone (CRH) and arginine vasopressin (AVP) [6, 10], 
factors that ultimately control the secretion of corticos-
teroids into the bloodstream upon stress.
Loss-of-function mutations in the MECP2 gene are the 
major cause of Rett syndrome (RTT), a neurodevelop-
mental disorder that primarily affects females [11]. In its 
classical presentation, RTT patients show motor impair-
ments, breathing abnormalities, loss of speech, intellec-
tual disability, repetitive behaviors, and autistic features 
[12]. Males usually have a severe and fatal neonatal 
encephalopathy (reviewed in [13]. To a lesser extent, 
MECP2 mutations are also responsible by other major 
neurodevelopmental disorders such as X-linked mental 
retardation, autism, Angelman syndrome or schizophre-
nia [14]. By contrast, individuals with the MECP2 dupli-
cation syndrome (MDS), that affects mainly males, show 
intellectual disability and autism [15]. The involvement of 
MeCP2 in multiple neurodevelopmental disorders dem-
onstrates that it occupies a central role in the postnatal 
development of the brain.
Importantly, RTT patients show a blunted decrease of 
around 50% of cortisol concentration from morning to 
evening, as compared with typical values of 90% decrease 
in healthy individuals [16]. Interestingly, RTT cortisol 
patterns are significantly related to mutation severity. 
Conversely, MDS patients showed an atypical diurnal 
cortisol response, with cortisol levels failing to show the 
typical increase after waking, and, again, altered cortisol 
patterns were associated with clinical severity [17].
Several different genetic mouse models have been 
generated that mimic the major human behavioral, neu-
roanatomical, and biochemical aspects of the different 
disorders (reviewed in [18]), allowing the study of the 
underlying mechanisms. Mouse models of RTT show 
an altered corticosterone response to stress [10, 19–21] 
suggesting dysregulation of the HPA axis and an abnor-
mal stress response. Indeed, Crh gene is a direct target 
of MeCP2 [22, 23] and mouse models of RTT show dys-
regulated levels of Crh [10, 21, 22, 24].
In this scenario, it is plausible that decreased function-
ality of MeCP2 early in life, as that seen in RTT patients, 
will impact the epigenetic programming of the HPA axis 
thereby affecting their vulnerability to develop anxiety 
and stress-related disorders later in life, when encounter-
ing a stressor. In fact, anxiety-like behavior is a promi-
nent component of RTT’s behavioral phenotype [25]. 
Whereas girls with RTT display altered anxious behav-
ior, female mice model of RTT show reduced reactivity 
in anxiogenic tests such as the elevated plus maze [26, 
27]. Moreover, in boys with MDS anxiety is co-morbid 
[28] and transgenic mice that overexpress two to three-
fold normal MeCP2 levels show heightened anxiety-like 
behavior [26]. On the one hand, dysregulation of MeCP2 
levels and/or function can modulate susceptibility to 
develop anxiety and stress-related disorders in MECP2-
related disorders. On the other hand, MECP2 gene can 
itself constitute a genetic risk factor for the development 
of anxiety and stress-related disorders, though future 
studies are needed to investigate this later possibility.
To our knowledge, the effects of ELS in anxious behav-
ior in Mecp2-deficient mice have not been experimen-
tally tested. In this study, we used Mecp2 heterozygous 
(Mecp2.het) and wild-type (WT) female mice that were, 
or were not, submitted to maternal separation (MS), a 
classical rodent paradigm to study ELS [29, 30]. Inter-
fering at early developmental timepoints can affect the 
programming of the HPA axis with consequences in 
emotional behavior and neuronal functionality later in 
life [29, 31]. Therefore, young adult mice were tested in 
the elevated plus maze (EPM) and open field (OF) to 
measure anxiety-like behaviors and in the forced swim-
ming test (FST) to evaluate depression-like behavior. 
After a second exposure to the EPM (in bright, aversive 
conditions), animals were sacrificed and FOS proto-
oncogene (c-FOS) immunohistochemistry was used to 
analyze neuronal activation in anxiety- and stress-related 
brain regions [32]. Finally, we checked whether c-FOS 
co-localization with either CRH and AVP in the paraven-




For this study, we used the Mecp2.het females and their 
wild-type littermates from our colony. To establish the 
colony, we purchased Mecp2.het females from Jackson 
Laboratory (stock #003890, B6.129P2(C)-Mecp2tm1.1Bird/J) 
[33] and maintained breeding pairs at our animal facil-
ity, by crossing these females with C57Bl/6J WT males. 
Experimental females were weaned at postnatal day 
(PND) 23 and housed in groups of 2–5 animals in stand-
ard laboratory cages with controlled humidity and 
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temperature (22 °C), a 12:12-h light/dark cycle, and water 
and food available ad libitum. Genotyping was performed 
with DNA extracted from ear biopsies according to the 
protocol supplied by the Jackson Laboratory for this 
strain. Behavioral testing was performed during the dark 
phase of the animals.
All the procedures were carried out in strict accord-
ance with the EU directive 2010/63/EU. The protocols 
were approved by the Ethics in Animal Experimentation 
Committee of the University of Valencia.
Early‑life stress (ELS)
To induce ELS we used the MS protocol. From PND3 to 
PND21 pups (WT-MS, n = 13; Mecp2.het-MS, n = 18) 
were separated from the dam as a group, and kept in a 
new cage filled with sawdust and warming red light for 3 
h per day, after which pups were returned to their home 
cage. Control animals were included (WT-naive, n = 14; 
Mecp2.het-naive, n = 12) that were maintained undis-
turbed with their dams in the home cage until weaning. 
All these animals were subjected to the battery of behav-
ioral tests.
Open field (OF)
Animals (WT-naive, n = 14; WT-MS, n = 13; Mecp2.
het-naive, n = 12; Mecp2.het-MS, n = 18) were allowed 
to explore a squared arena (50 cm × 50 cm × 50 cm) in 
a 20-min session, under red light illumination. The total 
distance travelled was used a measure of activity and the 
distance travelled and time spent in a predefined center 
area (25 cm × 25 cm) versus the rest of the arena was 
used to assess anxiety-like behavior. Movement of mice 
was tracked using an automated tracking system (ANY-
mazeTM Video Tracking System, Stoelting Co., Wood 
Dale, IL, USA).
Forced swimming test (FST)
To assess depressive-like state mice were tested in the 
FST. Mice (WT-naive, n = 14; WT-MS, n = 13; Mecp2.
het-naive, n = 12; Mecp2.het-MS, n = 18) were put in an 
inescapable transparent jar filled with water and allowed 
to swim for a 5-min period. The time animals spent 
immobile was measured. Mice were dried out in paper 
towel before they were returned to their home cage.
Elevated plus maze (EPM)
Mice were tested in the EPM in two sessions (WT-naive, 
n = 14; WT-MS, n = 13; Mecp2.het-naive, n = 12; Mecp2.
het-MS, n = 18). The first EPM session was the first test 
of the behavioral battery and was performed under red 
light conditions. The second EPM session was the last 
test of the battery and was performed under bright light, 
aversive conditions, and 1 h after the test animals were 
sacrificed. The maze consisted of two opposing closed 
arms (in cm, 30 length × 6 wide × 15 height) and two 
opposing open arms (in cm, 30 length × 6 wide) extend-
ing from a common central region (6 × 6 cm) to form 
a ‘plus’ shape. The arms were elevated 40 cm above the 
floor. In a single 5-min trial, animals were placed in the 
center of the maze and the time spent, distance travelled 
and number of entries in the open and closed arms were 
recorded. Movement of mice was tracked using an auto-
mated tracking system (ANY-mazeTM Video Tracking 
System, Stoelting Co.).
Histology
A random subset of the animals used in the behavioral 
battery was selected for anatomical studies. Animals 
(WT-naïve, n = 4; Mecp2.het-naïve, n = 5; WT-MS, n 
= 7; Mecp2.het-MS, n = 6) were deeply anaesthetized 
1 h after the last EPM session (bright conditions), using 
a mixture of ketamine (75 mg/kg) and medetomidine 
(1 mg/kg) and transcardially perfused with saline solu-
tion followed by 4% paraformaldehyde in 0.1 M phos-
phate buffer (PB, pH 7.4). Brains were carefully removed 
from the skull, post-fixed in the same fixative for 4 h and 
placed into a 30% sucrose solution in 0.1 M phosphate 
buffered saline (PBS, pH 7.6) until they sank. The brains 
were then frozen and cut in six series of 40-μm-thick 
coronal sections with a freezing microtome. Free-floating 
sections were frozen in 30% sucrose in PB/0.02% sodium 
azide (0.1 M pH 7.4) for their posterior processing.
c‑FOS immunohistochemistry
One out of six brain slices parallel series of each subject 
was processed for the immunohistochemical detection of 
c-FOS. To do so, endogenous peroxidase was inactivated 
with 1%  H2O2 in tris-buffered saline (TBS) (0.05M, pH 
7.6) for 30 min at room temperature (RT). Next, sections 
were incubated in blocking solution containing 3% nor-
mal goat serum (NGS) in TBS-triton X100 (Tx) 0.3% for 
1 h at RT. Then, sections were incubated in rabbit anti-
c-FOS (1:10000, sc-52, Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) in TBS-Tx with 3% NGS 24 h at 4 °C, fol-
lowed by an incubation with biotinylated goat anti-rabbit 
IgG (1:200, BA1000, Vector Laboratories, Peterborough, 
UK) in TBS-Tx with 2% NGS for 2 h at RT. Afterwards, 
sections were incubated in ABC Elite (1:50, PK-6100, 
Vector Laboratories) in TBS-Tx for 90 min at RT. Finally, 
the resulting peroxidase labelling was revealed with 
0.025% 3-3′-diaminobenzidine (DAB, Sigma, St. Louis, 
MO, USA) in PB (0.1 M, pH 8.0) and 0.01%  H2O2 for 
25 min. Sections were mounted onto gelatinized slides, 
dehydrated in alcohols, cleared with xylene and cover 
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slipped with Entellan (Merck Millipore, Burlington, MA, 
USA).
c‑FOS/AVP and c‑FOS/CRH double immunofluorescence
We obtained double immunofluorescent labelling for 
c-FOS/AVP and c-FOS/CRH in two out of six brain 
slices parallel series of each subject. Brain slices were 
first incubated with 1% sodium borohydride in 0.05 M 
TBS for 30 min at RT to block the endogenous fluores-
cence of the tissue. Next, sections were incubated in a 
blocking solution containing 3% normal donkey serum 
(NDS) in TBS-Tx 0.3% for 1 h at RT. Afterwards, each 
series was incubated for 48 h at 4 °C with a mixture of 
primary antibodies containing rabbit anti-AVP (1:1000, 
AB1565, Sigma-Aldrich) or rabbit anti-CRH (1:500, 
C5348, Sigma-Aldrich) and goat anti-c-FOS (1:500, 
sc-52, Santa Cruz Biotechnology, Inc.) in TBS-Tx 0.3%/ 
NDS 2%. Next, brain slices were incubated for 90 min at 
RT with appropriate secondary antibodies Rhodamine 
Red-X Donkey anti-Rabbit (1:200, 711-295-152, Jackson 
ImmunoResearch) and Alexa Fluor® 488 Donkey Anti-
Goat (1:200, A-11055 Invitrogen) in TBS-Tx0.3% with 
2% NDS. Finally, sections were mounted onto gelatinized 
slides and cover-slipped with fluorescence mounting 
medium (Fluoromount, Merck).
Image acquisition, processing, and mapping
After c-FOS immunohistochemistry, we quantified 
c-FOS-positive nuclei in representative levels (according 
to the stereotaxic atlas of Paxinos & Franklin [34] of the 
bed nucleus of the stria terminalis lateral division, dor-
sal part (BSTLD; Bregma 0.38/0.02 mm), the ventral part 
of the lateral septum (LSV; Bregma 0.62/− 0.10 mm), 
the paraventricular hypothalamic nucleus (Pa; Bregma 
− 0.7/− 1.06 mm), the paraventricular thalamic nucleus 
(PV; Bregma − 0.94/− 2.18 mm) and the dentate gyrus 
(DG; Bregma − 1.34/− 2.92 mm). In addition, neuro-
anatomical references, as the anterior commissure, were 
used to reduce variability between the photomicro-
graphs. Photomicrographs of these frames were obtained 
in both hemispheres (when possible) using a digital cam-
era (Leica DFC495, Wetzlar, Germany) attached to a 
microscope Leitz DMRB (Leica AG, Wetzlar, Germany) 
with a × 20 objective (counting frame of 441 × 330 μm) 
in the case of BSTLD and LSV, and in the case of Pa, 
PV and DG they were photomicrographed with a × 10 
objective (counting frame of 881 × 661 μm). After that, 
positive cells of each photomicrograph were counted 
manually using Fiji [35] cell counter plugin by an experi-
menter blind to the condition of the animals.
After c-FOS/AVP and c-FOS/CRH double immuno-
fluorescence, photomicrographs of both hemispheres at 
the level of Pa (Bregma − 0.7/− 1.06 mm) were obtained 
using Leica TCS SPE confocal microscope. Then, an 
experimenter blind to the condition of the animals 
counted the number of c-FOS-positive nuclei using the 
ImageJ Cell Counter analysis tool and co-expression of 
these nuclei with either AVP or CRH was verified visu-
ally and the number of double immunoreactive cells 
registered.
Statistical analysis
Behavioral and histological data were analyzed with two-
way ANOVA with treatment (naïve or MS) and geno-
type (WT or Mecp2.het) as between-subject sources of 
variance, followed by post hoc Bonferroni correction for 
multiple tests. Significance was set at p < 0.05. Data were 
analyzed using the software IBM SPSS Statistics 22.0.
Results
WT and Mecp2.het adolescent females (age 5 to 6 weeks 
old), naive and MS groups, were assessed for anxiety-like 
and depressive-like states to study the effects of Mecp2 
and ELS interaction of in the vulnerability of animals to 
adversity later in life. Thus, experimental subjects were 
submitted to tests starting with the EPM, OF, FST, and 
finishing with a second EPM performed in bright light 
conditions, 1 h after which animals were sacrificed to 
assess c-FOS activation patterns.
MS renders female mice more resilient to anxiety‑ 
and depressive‑like behaviors, an effect recapitulated 
by MeCP2 deficiency
Elevated plus maze
Animals were first tested in the EPM (under red light 
conditions) in a single 5-min session. No differences were 
observed among groups in the total distance travelled in 
the maze (Fig. 1A). However, two-way ANOVA revealed 
a statistically significant genotype effect (F(1, 53) = 8.633, 
p = 0.0049) in which Mecp2.het females spent more time 
in the open arms than WT animals (Fig. 1B), revealing a 
decreased anxiety-like phenotype in Mecp2.het females. 
We could not observe here an effect of the MS, as statis-
tical analysis revealed no significant differences (p > 0.5; 
Fig. 1B).
Open field
Spontaneous locomotor activity and exploration were 
measured in the OF apparatus in a 20-min session. When 
analyzing the total distance travelled in the maze, two-
way ANOVA showed a statistically significant genotype 
effect (F(1, 53) = 8.461, p = 0.0053; Fig. 1C) with Mecp2.
het females travelling a smaller total distance than their 
WT controls. Regarding time spent in the center of the 
apparatus in relation to the remaining area, we did not 
find a statistically significant effect of any factor (p > 0.05; 
Fig. 1D).
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Forced swimming test
The performance of WT and Mecp2.het females was 
evaluated in the FST by measuring the immobility time 
in a 5-min session. Two-way ANOVA revealed a sta-
tistically significant genotype effect (F(1, 51) = 27.09 p 
< 0.0001; Fig.  1E) showing that Mecp2.het females have 
lower immobility times than WT animals, indicative 
of an antidepressant-like phenotype. In addition, we 
also observed a trend towards significance in group x 
genotype interaction effect (F(1, 51) = 3.023 p = 0.0881; 
Fig. 1E). Post hoc comparisons showed that naïve Mecp2.
het females have lower immobility times than naïve WT 
Fig. 1 Young adult Mecp2 heterozygous females show reduced anxiety‑like and depressive‑like behaviors. WT and Mecp2.het females, both naive 
and MS groups, were tested in the EPM, OF, and FST to assess anxiety‑like and depressive‑like behaviors (WT‑naive, n = 14; WT‑MS, n = 13; Mecp2.
het‑naive, n = 12; Mecp2.het‑MS, n = 18). In the EPM, A no differences were found among groups in the total distance travelled in the maze, but 
B Mecp2.het females spent significantly longer time in the open arms of the maze as compared to WT littermates. In the open field, C Mecp2.
het females showed a reduction in the total distance traveled in the maze, as compared to WT animals, but D no differences were found in the 
percentage of time spent in center among groups. In the FST, E Mecp2.het females spent significantly less time immobile than their WT littermate 
controls. EPM, elevated plus maze; FST, forced swim test; Mecp2.het, Mecp2 heterozygous females; MS, maternal separation; OF, open field; WT, wild 
type; vs, versus. **p < 0.01, ***p < 0.001
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animals (WT-naive vs. Mecp2.het-naïve, t (51) = 4.757 p 
< 0.0001). In the MS groups, no statistically significant 
differences in immobility times were detected between 
WT and Mecp2.het females (WT-MS vs. Mecp2.het-MS, 
t(51) = 2.625 p = 0.0684; Fig. 1E). This data suggests that 
MS induces a change in depressive-like behavior in WT 
females, and that deficiency of MeCP2 in the Mecp2.het 
females per se occludes this phenotype. Although we do 
not observe an effect of MS in Mecp2.het females, we 
cannot exclude that it can be masked by a floor effect 
given the already very low immobility time in the Mecp2-
naive group.
Elevated plus maze‑bright
Finally, all animals were tested in a more anxiogenic ver-
sion of the EPM, under bright light conditions. Here, no 
differences were observed in the total distance travelled 
among groups (p > 0.5; Fig.  2A), showing that in this 
environment general activity is not affected by either 
genotype or prior stress experience. However, when we 
analyzed the percentage of time spent in the open arms 
of the maze, two-way ANOVA confirmed the geno-
type effect clearly seen in the previous tests, and fur-
ther revealed a MS group effect. Specifically, Mecp2.het 
females show reduced anxiety levels, as revealed by the 
significantly higher percentage of time spent in the open 
arms when compared with WT animals (genotype effect 
F(1, 53) = 9.095; p = 0.0039). Additionally, MS significantly 
increased the percentage of time spent in the open arms 
as compared with naïve animals (group effect F(1, 53) = 
9.304; p = 0.0036; Fig.  2B). Thus, WT and Mecp2.het 
females exposed to MS show lower levels of anxiety in 
face of an anxiogenic situation.
MS and Mecp2 deficiency decrease neuronal activation 
in the paraventricular nuclei upon exposure to a stressor
Mice were sacrificed 1 h after exposure to the bright EPM 
to allow for subsequent quantification of c-FOS-positive 
nuclei in brain regions (i) known to be activated after 
EPM exposure and (ii) related to stress and anxiety pro-
cessing [32]. In the Pa, statistical analysis revealed a sig-
nificant genotype x group interaction effect (Fig. 2C, D; 
F(1, 16) = 5.801 p = 0.028). Post hoc tests showed that MS 
reduced the number of c-FOS-positive nuclei in WT ani-
mals (Bonferroni correction; F(1, 16) = 24.453 p < 0.001). 
In addition, Mecp2 deficiency resulted in a strong reduc-
tion of c-FOS-positive nuclei, as that seen in the Mecp2.
het-naive females, when compared to WT-naive animals 
(F(1, 16) = 14.520 p = 0.002) and MS did not significantly 
add up to the effect (p > 0.5).
Similarly, in the PV, we found a significant effect of both 
group (F(1, 18) = 5.382 p = 0.032) and genotype (F(1, 18) = 
6.990 p = 0.017). Overall, MS resulted in a reduction 
of c-FOS-positive nuclei, particularly noticed in WT 
animals, and Mecp2.het females had a lower number 
of c-FOS-positive nuclei than WT animals (Fig.  2E). In 
these two brain regions, we cannot exclude that the lack 
of effect of MS in the number of c-FOS-positive nuclei 
observed in Mecp2.het females is masked by the fact that 
naive Mecp2.het females have already very low numbers 
of c-FOS-positive cells.
In the BSTLD and LSV, regions known to be activated 
by EPM, we did not observe statistically significant dif-
ferences in the number of c-FOS-positive nuclei between 
genotypes or groups, though the tendency towards 
low density of c-FOS nuclei in WT-MS and Mecp2.het 
females was similar to that found in Pa and PV (p > 0.5; 
Fig. 2F, G).
Finally, no significant differences were found in the DG 
with respect to genotype or group (p > 0.5; Fig. 2H).
MS and Mecp2 deficiency decrease the density 
of double‑labeled c‑FOS/CRH neurons in the Pa
Since the most significant effects of both Mecp2 defi-
ciency and MS in c-FOS-positive neurons were found in 
the Pa (Fig. 2C, D), we next asked whether the significant 
reduction in neuronal activation seen in WT-MS and 
Mecp2.het animals was due to a decrease in the activa-
tion of CRH neurons, AVP neurons, or both. To do so, 
we quantified the density of c-FOS-positive nuclei co-
localizing with either CRH- or AVP-positive neurons 
(Fig.  3A–D). Data revealed a statistically significant 
genotype x group interaction in the number of c-FOS 
nuclei co-localized with CRH-positive neurons (F(1, 17) = 
4.920 p = 0.044; Fig. 3A, C). Post hoc tests showed that 
MS reduced the number of c-FOS/CRH double-labeled 
neurons in WT animals (Bonferroni correction, F(1, 14) 
= 13.461 p = 0.003). Further, Mecp2 deficiency per se 
resulted in a strong reduction of c-FOS/CRH double-
labeled neurons (WT-naive vs Mecp2.het-naive, F (1, 14) = 
8.740 p = 0.010; Mecp2.het-naive vs Mecp2.het-MS, p > 
0.5).
By contrast, no statistically significant effects of either 
factor were found for the density of c-FOS/AVP double-
labeled neurons (Fig. 3B, D, p > 0.5). Previous studies sug-
gested and increase in Avp expression levels after MS [6]. 
In the same line, although not reaching statistical signifi-
cance, we found an average 60% increase in the density of 
AVP neurons in the Pa in WT-MS animals with respect 
to WT-naive mice (p = 0.055). On the other hand, the 
density of AVP cells in the Pa was not affected by Mecp2 
genotype (data not shown), in agreement with our previ-
ous study [36].
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Fig. 2 Mecp2 haplodeficiency and maternal separation reduced anxiety‑like behavior and neuronal activation in the paraventricular nuclei upon 
stress. WT and Mecp2.het females, both naive and MS animals, were re‑exposed to the EPM now under bright light conditions, a more aversive 
version (WT‑naive, n = 14; WT‑MS, n = 13; Mecp2.het‑naive, n = 12; Mecp2.het‑MS, n = 18). A No differences were found among groups in the 
total distance travelled in the maze. B Mecp2.het females spent significantly longer time in the open arms of the maze, as compared to WT 
littermates, an effect further increased by MS. One hour after behavioral testing in the aversive EPM, a subset of the animals was sacrificed for 
c‑FOS immunohistochemistry and quantification (WT‑naïve, n = 4; WT‑MS, n = 7; Mecp2.het‑naïve, n = 5; Mecp2.het‑MS, n = 6). C Representative 
photomicrographs of c‑FOS staining in the paraventricular hypothalamic nucleus of WT‑naive, C’ Mecp2.het‑MS, C” WT‑MS, and C”’ Mecp2.
het‑naive. Quantification of c‑FOS‑positive neurons in WT and Mecp2.het females, both naive and MS groups, in D Pa, E PV, F BSTLD, G LSV, and H 
DG. Pa, paraventricular hypothalamic nucleus; PV, paraventricular thalamic nucleus, BSTLD, bed nucleus of stria terminalis lateral division, dorsal part; 
LSV, lateral septum, ventral part; DG, dentate gyrus of the hippocampus; EPM, elevated plus maze; Mecp2.het, Mecp2 heterozygous females; MS, 
maternal separation; WT, wild type; vs, versus. *p < 0.05, **p < 0.01, ***p < 0.001
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Discussion
In this study, we used female mice with Mecp2 haplode-
ficiency to study the interaction between MeCP2 and MS 
in anxiety-like behavior and in the functionality of under-
lying neuronal circuits. We found that, in WT females, 
MS induced a reduction in anxiety and a concomitant 
significant decrease in the activation of CRH neurons in 
the Pa, upon exposure to the EPM. Further, compared 
to WT littermates, adolescent Mecp2.het females show 
reduced anxiety and depressive-like behavior, accompa-
nied by decreased activation of the CRH neuronal pop-
ulation in the Pa. Importantly, MS did not significantly 
affect any of those measures in Mecp2 mutant females. 
Overall, our data suggests that a MeCP2-dependent 
mechanism is involved in controlling neuronal activity 
in stress-related circuits that are also responsive to ELS. 
And, importantly, a reduction of MeCP2 activity is suf-
ficient to mimic MS effects.
Mecp2 haplodeficiency recapitulates the effects of MS 
in anxiety‑like behavior and in neuronal activation 
in the paraventricular nuclei
ELS can induce changes in gene expression, physiology 
(stress response) and behavior later in life. In the current 
study, we show that animals that were maternally sepa-
rated (MS groups) display a reduction in the anxiety lev-
els when tested in the bright EPM.
Previous studies demonstrated that MeCP2 is one 
of the factors mediating the effects of ELS in cogni-
tive and emotional behaviors in mice [6]. Importantly, 
Mecp2 haplodeficiency per se resulted in low levels of 
anxiety, mimicking the MS effects. In its first description, 
Mecp2.het females were reported as being asymptomatic 
at young ages, taking up to 6 months of age for 50% of 
females to develop overt symptoms [33]. Later though, 
we have shown that Mecp2.het pups have a delay in the 
development and acquisition of neurological reflexes 
Fig. 3 Mecp2 haplodeficiency and maternal separation reduced the density c‑FOS/CRH neuronal population in the paraventricular hypothalamic 
nucleus. Representative photomicrographs of A c‑FOS/CRH and B c‑FOS/AVP double immunofluorescence in the paraventricular hypothalamic 
nucleus (WT‑naïve, n = 4; WT‑MS, n = 7; Mecp2.het‑naïve, n = 5; Mecp2.het‑MS, n = 6). The number of c‑FOS‑positive cells that colocalize with 
CRH neurons was significantly reduced in Mecp2.het females and upon maternal separation. Quantification of the number of c‑FOS neurons that 
colocalize with C CRH or D AVP. AVP, arginine vasopressin; c‑FOS, FOS proto‑oncogene; CRH, corticotropin‑releasing hormone; Mecp2.het, Mecp2 
heterozygous females; MS, maternal separation; WT, wild type; vs, versus. *p < 0.05; **p < 0.01
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[37], suggesting that Mecp2 haplodeficiency at such 
young ages could affect the development of critical peri-
ods, and have an impact later in life. Here, we provide 
evidence that adolescent Mecp2.het females show indeed 
an altered sensitivity to early-life stress. In particular, at 6 
weeks of age, Mecp2.het females present with less anxiety 
and less depressive-like behaviors, as compared to WT 
animals. Our data agrees with a previous study showing 
decreased anxiety in the EPM of 5 weeks old Mecp2.het 
females of mixed background [26]. More recently, Vogel 
Ciernia and colleagues [27] also reported increased time 
spent in the open arms of the EPM in 6–8 weeks old 
Mecp2.het females of the strain used in the present study. 
However, other studies using Mecp2-deficient models 
have reported conflicting results when assessing anxiety-
like behavior.
To the reduction of the anxious phenotype of Mecp2.
het females might contribute the genetic background of 
the dam by affecting maternal behavior, which in turn 
will affect pup’s response to a stressor [38, 39]. In this 
regard, Mecp2.het dams produce smaller litters and often 
neglect and cannibalize their offspring [40], in addition 
to impairments in maternal behavior [41]. In fact, stud-
ies using C57BL/6 animals (the background of our animal 
model) suggest that this strain shows resilience to MS, 
that could be attributed to the fact that these animals are 
poor breeders and dams [39, 42]. Altogether, cross-fos-
tering studies to minimize the impact of maternal care on 
the offspring anxiety-like behaviors, ascribed to Mecp2 
genotype and/or strain, should be considered to clarify 
the effects here observed. Cross-fostering with CD-1 
strain, which are good breeders, has actually proven ben-
eficial in the evaluation of other RTT-like phenotypes 
[27]. Moreover, Lonetti and colleagues [43] showed that 
early life environmental enrichment, starting at PND10, 
rescued the anxious phenotype of young adult Mecp2+/− 
females. These results warrant future studies disen-
tangling the type and time windows of environmental 
interventions that could be beneficial to ameliorate RTT 
phenotypes.
A recent study in 6 months old, symptomatic, Mecp2.
het questions that this phenotype is solely due to anxi-
ety alterations. Strikingly, Flores Gutiérrez et  al. [44] 
found that Mecp2.het females with trimmed whiskers did 
not show the anxiolytic phenotype in the EPM, suggest-
ing that sensory hypersensitivity could be an important 
contributor of lowered anxiety. Nonetheless, our results 
showing decreased activation of the CRH neurons of the 
paraventricular nucleus indeed support a reduced anxi-
ogenic response (see below). Taken together, these results 
reflect the complexity of assessing the causes of aberrant 
behaviors in both mouse models and RTT patients, given 
the sensory and motor impairments that characterize the 
disease. In the case of patients, this is further compli-
cated by communication impairments. At the same time, 
our data supports the use of young Mecp2.het, largely 
pre-symptomatic females, as a valid model to study non-
motor phenotype alterations.
EPM is an anxiogenic stressor and exposure to the 
maze induces neuronal activation in several brain areas 
associated with stress and anxiety [32, 45]. In our study, 
WT-MS animals showed a significant reduction in the 
number of c-FOS neurons specifically in the Pa and PV 
regions, as compared to naive animals, after EPM expo-
sure. However, naive Mecp2.het females show low num-
bers of c-FOS neurons in the same regions, and MS has 
no additional effect. Our results show that MS precludes 
the activation of Pa and PV neurons, normally activated 
upon EPM exposure, and indicate that this may be a 
MeCP2-dependent process, as deficiency of Mecp2 per se 
also precludes the activation of such neurons.
Mecp2 haplodeficiency and MS preclude the activation 
of CRH neurons in the Pa
The Pa is a stress-responsive brain region and a key 
center of the HPA axis, containing CRH neurons that 
control adrenocorticotrophic hormone (ACTH) release 
from the hypophysis, which in turn activates the adrenal 
release of corticosterone to the bloodstream. ELS induces 
activity-regulated gene expression and alters the distribu-
tion of epigenetic marks, which MeCP2 reads, thereby 
modulating gene expression of a specific set of genes later 
in life [6, 7]. One of such genes is Crh, as rats subjected 
to MS showed reduced occupancy of several transcrip-
tion factors, including MeCP2, in the promoter region of 
Crh gene accounting for its upregulation [23]. Our results 
show that both MS and MeCP2 deficiency specifically 
precluded the activation of CRH neurons in the Pa, con-
cordant with the decreased anxiety phenotype exhibited 
by the animals. In line with our results, selective inacti-
vation of Mecp2 in hypothalamic neurons decreases Crh 
mRNA in the Pa [19]. Instead, the transgenic Mecp2308 
mouse model, expressing a mutated form of MeCP2, pre-
sents with heightened anxiety and elevated levels of Crh 
expression in the hypothalamus [10, 20, 24]. The authors 
attributed this to the fact that mutated MeCP2 fails to 
occupy the proximal promoter of the Crh gene, which 
associates with elevated levels of Crh expression [10]. 
Indeed, in vitro studies with rat embryonic hypothalami 
showed that MeCP2 is necessary for maintaining basal 
levels of Crh gene expression, as MeCP2 knockdown 
leads to increased expression of Crh [46]. On the other 
hand, mice with double or triple levels of MeCP2 showed 
increased levels of Crh and displayed heightened anxiety-
like behavior when subjected to the EPM and to the light-
dark box [22]. The influence of strain background on 
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behavior performance can be contributing to the appar-
ently contradictory results of the different studies [26]. 
Nevertheless, we cannot exclude that zygosity, sex [20], 
or even Mecp2 mutation type could also account for the 
apparently contradictory effects of MeCP2 on anxiety.
Our data showing reduced neuronal activation of 
CRH neurons, together with other studies showing a 
decrease [19] or increase [10, 20, 21, 46] of Crh expres-
sion in Mecp2-deficient models suggest that feedback 
loops ensuring the correct function of HPA axis are com-
promised in Mecp2 mouse models. Consistent with this, 
modulation of the corticosteroid levels has proven ben-
eficial in these models with a positive impact in locomo-
tor/exploratory behavior, motor symptoms and lifespan 
[47, 48]. The analysis of serum (or plasma) corticosterone 
levels was not performed and stands as a caveat in this 
study. Nevertheless, our results of a decreased activation 
of CRH neurons in the Pa, upon exposure to an anxio-
genic situation, provide indirect evidence that the levels 
of blood corticosterone are decreased or not altered in 
the Mecp2.het females. In line with our results, Mecp2+/− 
females in a mixed background are less anxious and have 
an abnormal corticosterone response to stress, either 
with no differences or with decreased levels of corticos-
terone, when compared to control animals [26]. Moreo-
ver, Cosentino and colleagues [20], using a different RTT 
mouse model, showed that upon restrain stress  Mecp308 
females have lower levels of corticosterone than wild-
type females.
Our data did not reveal a statistically significant effect 
of either MS or Mecp2 deficiency in the activation of 
AVP neurons. Previous data showed that MS induced 
hypomethylation at the Avp enhancer region, and a low 
presence of bound MeCP2 in the same region, thereby 
increasing Avp expression specifically in the Pa [6]. Also, 
mice lacking fully functional MeCP2 (Mecp2308 null), 
but not mice with MeCP2 haplodeficiency  (Mecp2308 
het), show an increased expression of Avp in the hypo-
thalamus [20]. In our study, although apparently higher 
compared to WT-naive, the high variability in the density 
of hypothalamic AVP neurons prevented us from draw-
ing strong conclusions regarding the effect of MS. On the 
other hand, Mecp2 deficiency had no effect in the den-
sity of AVP neurons in the Pa, in line with our previous 
results [36] and with the results obtained in mice with a 
selective inactivation of Mecp2 in hypothalamic neurons 
[19].
Regarding the PV, this thalamic nucleus is a key hub of 
the circuits regulating emotional behaviors, and displays 
important connections with the hypothalamus, BST, and 
amygdala [49]. Indeed, its function is essential to regulate 
responses to stressors [50]. Thus, the decreased activa-
tion seen in the PV of Mecp2.het females might reflect, 
as in the case of Pa, an inability to appropriately respond 
to an anxiogenic situation. Finally, although we did not 
find a statistically significant effect in the BSTLD and 
LSV, these structures display a trend towards hypoactiva-
tion in both Mecp2.het and WT-MS females, similar to 
what was found in Pa and PV. This trend was not seen 
in the in the DG, suggesting that differences observed in 
c-FOS induction after EPM are specific of the emotional 
circuits.
Early‑life environment and Mecp2 interact to modulate 
the risk of developing psychopathology in RTT and other 
psychiatric disorders.
MECP2 constitutes a shared genetic risk factor to mul-
tiple neurodevelopmental disorders; primarily to RTT 
[11] and, to a lesser extent, to a range of other neurode-
velopmental disorders including autism [51], schizophre-
nia [52], or intellectual disability [53] and to MDS [15]. 
Importantly, disturbances of MeCP2 during critical peri-
ods definition can constitute a risk factor for psychopa-
thology in neurodevelopmental disorders, but also for 
anxiety- and stress-related disorders, by impairing the 
proper maturation of the HPA axis, which constitutes 
per se a risk factor for the development of psychopathol-
ogy [2]. Indeed, long-time empirical reports (from clini-
cians and parents) suggest that anxiety is an important 
component of the behavioral phenotype of RTT. More 
recently, scientific studies confirmed disturbances in anx-
iety in patients with RTT [25], MDS [28], and in Mecp2 
mouse models [10, 22]. In the same line, Consentino 
and colleagues [24] showed that transgenic Mecp2308/Y 
mice show susceptibility to develop PTSD-like symp-
tomatology after a traumatic event, reinforcing the role of 
MeCP2 in psychopathology.
Conclusions
Data presented in this study suggest that deficiency 
of MeCP2 early in development, through the regula-
tion of the critical period of HPA axis, may underlie 
the alterations in anxiety behavior observed in adoles-
cent Mecp2.het females. Future studies using models 
that allow a spatiotemporal control of MeCP2 expres-
sion should be used in order to prove its involvement 
and explore the underlying molecular mechanisms. It 
is unquestionable that changes in MeCP2 expression 
affect anxiety-like behaviors. However, further investi-
gation is needed to fully elucidate the anxiety profile in 
RTT and MECP2-associated diseases. In addition, it is 
possible that there is currently an underreported asso-
ciation between MECP2, anxiety (panic disorder, pho-
bias, generalized anxiety disorder) and stress-related 
disorders (posttraumatic stress disorder), and future 
studies in the field should screen for MECP2 variants 
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and also methylation levels (mCA and mCpG) of spe-
cific MeCP2 target genes (CRH, AVP, BDNF), which 
early in development are sensitive to the environment 
and modulate the response to stressors later in life.
In conclusion, this study provides evidence that a 
Mecp2-dependent mechanism is involved in controlling 
neuronal activity in stress-related circuits that are also 
responsive to early-life adversity. Moreover, data con-
firmed CRH pathway as a potential entry point for the 
treatment of anxiety in RTT and related conditions.
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